2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Biofluid Markers in Parkinson’s Patients and Correlation with Cognitive Profile

T. Yamasaki, R. Vivanco, J. Johnson, S. Ali, F. Schmitt, A. Glueck, A. Jacob, S. Hulou, M. Khashimov, K. Tackett, C. Logan, J. Stegemann, E. Song, E. Ostrakhovitch (Lexington, USA)
Biological Predictors of Clinical Domains in Isolated REM Sleep Behavior Disorder with and without Synucleinopathy and Dopamine Dysfunction

D. Weintraub (Philadelphia, USA)
Biomarker and Clinical Correlates of Restless Legs Syndrome (RLS) in Parkinson’s Disease: A Paradoxical Hyperdopaminergic State

SM. Fereshtehnejad, J. Valerio, N. Ayas (Vancouver, Canada)
Biomarker-Informed Survival Modelling Using Plasma Neurofilament Light and Clinical Predictors in a Prospective Multiple System Atrophy Cohort

V. Chelban, L. Lei, C. Lee, Y. Goh, I. Karagoz, R. Lee, H. Morris, N. Vijiaratnam, T. Foltynie, H. Houlden (London, United Kingdom)
Biomechanical Analysis of Gait Movement Disorders in Spinal Cord Injury and Its Implications for Rehabilitation Strategies

M. Gupta, B. Garg (New Delhi, India)
Bisphenol S: A Potential Environmental Modifier of LRRK2-Associated Parkinson’s disease

B. Talavera Andújar, J. Ghelfi, I. Goglia, M. Tziortziou, M. Borsche, C. Klein, E. Schymanski, A. Grünewald (Belvaux, Luxembourg)
Blood glucose homeostasis is conserved in patients with mild to moderate Spinocerebellar Ataxia type 2

R. Aguilera-Rodríguez, D. Almaguer-Gotay, A. álvarez-Sosa, M. Anidos-Machado, Y. Silva-Ricardo, D. Cuello-Almarales, A. Estupiñán-Rodríguez, L. Almaguer-Mederos (Holguín, Cuba)
Body Weight Increases After DBS in Parkinson’s Disease but Not Essential Tremor

C. Tinch, S. Brinkerhoff, H. Walker, S. Frank, C. Ferguson (Birmingham, USA)
Boosting cerebellum/M1 and PPC/M1 communication via tACS to improve cued gait in Parkinson’s disease patients unresponsive to auditory cueing strategies.

E. Pelosin, A. Botta, V. Romano, J. Nonnekes, M. Gilat, I. Maidan, A. Mirelman, L. Avanzino (Genova, Italy)
Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z